WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005103011) PROCESSES FOR PREPARING SUBSTITUTED N-ARYL-N’-[3-(1H-PYRAZOL-5-YL) PHENYL] UREAS AND INTERMEDIATES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/103011    International Application No.:    PCT/US2004/023880
Publication Date: 03.11.2005 International Filing Date: 21.07.2004
IPC:
A61K 31/415 (2006.01), A61P 25/18 (2006.01), A61P 25/22 (2006.01), A61P 25/24 (2006.01), C07D 231/16 (2006.01)
Applicants: ARENA PHARMACEUTICALS, INC. [US/US]; 6166 Nancy Ridge Drive, San Diego, CA 92121-3223 (US) (For All Designated States Except US).
FRITCH, John Robert [US/US]; (US) (For US Only).
CARLETON, Fiona M. [IE/US]; (US) (For US Only).
LALLY, Edward A. [US/US]; (US) (For US Only).
LI, Hongmei [CN/US]; (US) (For US Only).
TEEGARDEN, Bradley [US/US]; (US) (For US Only)
Inventors: FRITCH, John Robert; (US).
CARLETON, Fiona M.; (US).
LALLY, Edward A.; (US).
LI, Hongmei; (US).
TEEGARDEN, Bradley; (US)
Agent: SPRUCE, Lyle; Arena Pharmaceuticals, Inc., 6166 Nancy Ricge Drive, San Diego, California 92121-3223 (US)
Priority Data:
60/555,626 23.03.2004 US
Title (EN) PROCESSES FOR PREPARING SUBSTITUTED N-ARYL-N’-[3-(1H-PYRAZOL-5-YL) PHENYL] UREAS AND INTERMEDIATES THEREOF
(FR) METHODES DE PREPARATION DE N-ARYL-N'-[3-(1H-PYRAZOL-5-YL) PHENYLUREES] SUBSTITUEES ET LEURS INTERMEDIAIRES
Abstract: front page image
(EN)The present invention is directed to processes for the preparation of substituted phenylpyrazole ureas of Formula (I), that are useful as 5-HT2A serotonin receptor modulators for the treatment of disease.
(FR)La présente invention concerne des méthodes de préparation d'urées de phénylpyrazole substituées de formule (I), utiles comme modulateurs du récepteur de la sérotonine 5-HT2A destinés au traitement de maladies.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)